Latest Articles

Publication Date
GP says more women going to the UK for treatment - MSN

GP says more women going to the UK for treatment MSN

Published: April 30, 2025, 6:03 a.m.
GP says more women going to the UK for treatment - BBC

GP says more women going to the UK for treatment BBC

Published: April 30, 2025, 5:06 a.m.
Endometriosis treatment centre urgently needed - Dublin Gazette Newspapers

Endometriosis treatment centre urgently needed Dublin Gazette Newspapers

Published: April 29, 2025, 7 a.m.
Exploring the Future of Endometrial Cancer Treatment Market - openPR.com

Exploring the Future of Endometrial Cancer Treatment Market openPR.com

Published: April 28, 2025, 10:39 a.m.
Sinn Fein Calls For Endometriosis Treatment Centre - Newstalk

Sinn Fein Calls For Endometriosis Treatment Centre Newstalk

Published: April 24, 2025, 11:23 a.m.
Mary Lou McDonald calls for dedicated Endometriosis treatment centre and provision of excision surgery - vote.sinnfein.ie

Mary Lou McDonald calls for dedicated Endometriosis treatment centre and provision of excision surgery vote.sinnfein.ie

Published: April 23, 2025, 7:31 p.m.
The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval - Labiotech.eu

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval Labiotech.eu

Published: April 23, 2025, 1:01 p.m.
Chronic Pelvic Pain Treatment Market Size will Projected to Hit - openPR.com

Chronic Pelvic Pain Treatment Market Size will Projected to Hit openPR.com

Published: April 18, 2025, 12:17 p.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!